Boilerplate clauses

Copyright © 2025 LexisNexis

This subtopic focuses on boilerplate clauses in commercial business-to-business agreements. For information on commercial clauses more generally, see: Commercial clauses—overview.

For information on boilerplate in business-to-consumer contracts, see the section on ‘Consumer boilerplate’ below.

For information on boilerplate in public sector contracts, see the section on ‘Public sector boilerplate’ below.

The role of boilerplate

Lawyers work on a huge variety of transactions, but all of them will in some way involve written agreements. All of those agreements should contain some boilerplate clauses.

‘Boilerplate’ is the term used to describe the clauses that are included in an agreement to deal with the mechanics of how it works and those legal points that are relevant to most transactions. For further consideration of the role and importance of boilerplate clauses, see Practice Note: The role of boilerplate.

Boilerplate clauses are generally found at the beginning and the end of an agreement. Such clauses are often thought of as standard, miscellaneous provisions, but this is a very dangerous view to adopt. It is not unusual for a boilerplate clause to be the cause of litigation. Since a boilerplate clause

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

Existing user? Sign-in TAKE A FREE TRIAL
Powered by Lexis+®
Latest Life Sciences News

DSIT launches £50m Life Sciences Transformational R&D Investment Fund pilot

The Department for Science, Innovation and Technology (DSIT) has launched the Life Sciences Transformational R&D Investment Fund Pilot. The fund supports large-scale R&D projects with minimum total costs of £100m and offers grants typically ranging from 10–20% of project costs, capped at £25m per award.

EDQM publishes guidance on classification of active substances for supply

The European Directorate for the Quality of Medicines and Healthcare (EDQM) has published the 'Guidelines on key considerations in issuing recommendations on the classification of active substances as regards their supply (prescription and non-prescription status)', updating its approach to the classification of active pharmaceutical substances. The guidance, adopted by the Committee of Experts on the Classification of Medicines as Regards their Supply (CD-P-PH/PHO) and currently chaired by Sandra Monteiro of Infarmed, Portugal, sets out the factors to be considered when determining whether medicines should be prescription-only or available without a prescription.

DHSC launches call for evidence on 10 Year Workforce Plan

The Department of Health and Social Care (DHSC) has launched a call for evidence to inform development of a 10 Year Workforce Plan. The consultation seeks views from healthcare organisations, trade unions, royal colleges, employers, charities and those with relevant expertise. The workforce plan aims to support the 10 Year Health Plan for England by creating a new workforce model aligned with healthcare transformation from hospital to community care, analogue to digital systems and sickness to prevention approaches. The consultation closes on 7 November 2025.

MHRA, ASA and GPhC issue updated enforcement notice on advertising rules for prescription weight-loss medicines

The Medicines and Healthcare products Regulatory Agency (MHRA), together with the Advertising Standards Authority (ASA) and the General Pharmaceutical Council (GPhC), has issued an updated joint enforcement notice to clarify the rules on advertising prescription-only medicines (POMs) for weight management. The notice, directed primarily at pharmacies, provides guidance on prohibited advertising practices. Advertisers must avoid: (1) using terms referring to POMs such as ‘weight-loss injection’, ‘obesity treatment jab’ or ‘GLP-1’; (2) including imagery likely to be interpreted as denoting prescription medicines; and (3) advertising general weight-loss products and services in a way that directs consumers to other advertisements, such as website landing pages, that promote POMs. The MHRA confirmed that it has already taken action against more than 25 businesses in 2025 for promoting prescription-only weight-loss medicines to the public.

View Life Sciences by content type :  
News
Practice notes
Precedents
Q&As

Popular documents

Contributory negligence in personal injury claims

Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Glossary—Latin legal terms

Glossary—Latin legal termsDespite attempts in recent years to simplify the language used in legal cases, there are still a number of Latin phrases commonly used in personal injury claims. The following Latin phrases are listed in alphabetical order:Latin

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of
Contributory negligence in personal injury claims

Contributory negligence in personal injury claims

Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Glossary—Latin legal terms

Glossary—Latin legal terms

Glossary—Latin legal termsDespite attempts in recent years to simplify the language used in legal cases, there are still a number of Latin phrases commonly used in personal injury claims. The following Latin phrases are listed in alphabetical order:Latin

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of